Sharon Connaughton

Cooley advised Machinify, a provider of artificial intelligence-powered software transforming healthcare payments, on its definitive agreement to be acquired by New Mountain Capital.

Cooley advised Machinify, a provider of artificial intelligence-powered software transforming healthcare payments, on its definitive agreement to be acquired by New Mountain Capital.

Cooley advised Kpler, a fast-growing data and analytics firm on a mission to build one platform for global trade intelligence, on its acquisition of Spire Global’s maritime business for approximately $241 million.

Cooley advised Printify, a technology platform headquartered in Latvia that makes it possible for anyone, anywhere, to sell customized products with zero upfront investment, on its merger with Printful, a Latvia-based technology company that helps ecommerce sellers of all sizes use production-on-demand and other fulfillment solutions to turn their ideas into brands and products.

Cooley advised Chimagen Biosciences, a privately held biotechnology company, on its agreement to sell CMG1A46, a clinical-stage dual CD19 and CD20-targeted T-cell engager (TCE), to GSK, a global biopharma company, for an upfront payment of $300 million, plus success-based development and commercial milestone payments totaling up to $550 million.